{"product_id":"astro-practical-radiation-oncology-program-2023","title":"ASTRO Practical Radiation Oncology Program 2023","description":"\u003ch3\u003eASTRO Practical Radiation Oncology Program 2023\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 10 videos, size: 3.5 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: radiation oncologists, radiation oncology residents, radiation therapists, radiation dosimetrists, medical oncologists, surgeons, physicists, nurses, pathologists, and urologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eThis program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a coding update and a scientific overview.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch2\u003eTARGET AUDIENCE\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eThe activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation therapists, radiation dosimetrists, medical oncologists, surgeons, physicists, nurses, pathologists, and urologists.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003ch2\u003eLEARNING OBJECTIVES\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eUpon completion of this activity, participants should be able to do the following:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDiscuss various techniques for breast cancer patient set-up and motion management.\u003c\/li\u003e\n\u003cli\u003eDiscuss hypofractionation and ultra-hypofractionation techniques.\u003c\/li\u003e\n\u003cli\u003eIdentify the different treatment strategies for sarcoma based on clinical presentation.\u003c\/li\u003e\n\u003cli\u003eImplement different treatment techniques for sarcoma based on clinical scenario.\u003c\/li\u003e\n\u003cli\u003eDiscuss treatment of larynx cancers for different stages of disease.\u003c\/li\u003e\n\u003cli\u003eManage care of long-term survivors of larynx cancer.\u003c\/li\u003e\n\u003cli\u003eContour planning volumes to the current standard of care in lung cancer management.\u003c\/li\u003e\n\u003cli\u003eSelect appropriate dose\/fractionation schedule for common palliative scenarios in lung cancer management.\u003c\/li\u003e\n\u003cli\u003eKnow appropriate fractionation schemes for retreatment in the central nervous system, head and neck, and prostate.\u003c\/li\u003e\n\u003cli\u003eUnderstand the risk\/benefit ration of retreatment in the central nervous system, head and neck, and prostate and be able to communicate this to patients.\u003c\/li\u003e\n\u003cli\u003eAssess their existing brachytherapy capabilities for treatment of gynecologic cancers and evaluate ways to enhance access and capabilities in a community setting.\u003c\/li\u003e\n\u003cli\u003eSelect patients for appropriate treatment of recurrent or inoperable endometrial cancer and navigate anatomic or technical challenges to provide quality radiation care.\u003c\/li\u003e\n\u003cli\u003eIncorporate information to improve the management of primary and metastatic brain tumors.\u003c\/li\u003e\n\u003cli\u003eReturn to their teams with techniques to improve their radiosurgery programs in the treatment of primary brain tumors.\u003c\/li\u003e\n\u003cli\u003eComfortably differentiate patients with oligometastatic disease that may benefit from radiation therapy in the context of recent supportive studies.\u003c\/li\u003e\n\u003cli\u003eAssess their available resources and apply safe, effective radiation when indicated with greater comfort of dose, technique, timing, and prognostication principles specific to metastasis-directed radiation.\u003c\/li\u003e\n\u003cli\u003eDiscuss the multidisciplinary management of esophagogastric, borderline resectable pancreatic and rectal cancer.\u003c\/li\u003e\n\u003cli\u003eOptimize radiation techniques and plans for esophagogastric, borderline resectable pancreatic and rectal cancer.\u003c\/li\u003e\n\u003cli\u003eAssess updated dose limits to critical structures to minimize long term morbidity.\u003c\/li\u003e\n\u003cli\u003eDetermine what data and testing is available to tailor the use of androgen deprivation therapy in intermediate risk and post prostatectomy patients.\u003c\/li\u003e\n\u003cli\u003eExplain the combinations and sequencing of systemic therapies for high risk, node positive, and metastatic prostate cancer patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003col\u003e\n\u003cli\u003e Updates in Breast Cancer: Hypofractionation, Treatment Techniques, and Systemic Therapy\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eHypofractionation for Breast Cancer—Nicolas Prionas, MD, PhD\u003c\/li\u003e\n\u003cli\u003eBreast Radiation Techniques and Motion Management—Jolinta Lin, MD\u003c\/li\u003e\n\u003cli\u003eAdvances in Systemic Therapy for Breast Cancer—Cathie Chung, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Who, What and How of Sarcoma\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eOverview of Sarcoma—Manpreet Bedi, MD, MS\u003c\/li\u003e\n\u003cli\u003eMultidisciplinary Management of Sarcoma—Andrew Bishop, MD\u003c\/li\u003e\n\u003cli\u003eUnresectable and Metastatic Disease—Anusha Kalbasi, MD\u003c\/li\u003e\n\u003cli\u003eRadiation Technique and Case Presentation—Shauna Campbell, MD, DO\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eTreatment and Management of Larynx Cancer\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eEarly Stage Larynx Cancer—David Sher, MD, MPH\u003c\/li\u003e\n\u003cli\u003eLocally Advanced Larynx Cancer—Zain Husain, MD\u003c\/li\u003e\n\u003cli\u003eTreatment Strategies in Post Operative and Recurrent Larynx Cancer—Gary Walker, MD, MS, MPH\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eUpdates in Lung Cancer Management\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCurrent Management of Stage III Non Small Cell Lung Cancer—Saumil Gandhi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eNon Definitive Lung Options: Palliation and XRT Alone—Uzoma Iheagwara, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSmall Cell Lung Cancer Treatment Volumes—Sara Zakem, MD, BS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eReirradiation for Prostate, CNS and Head and Neck Cancers\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eReirradiation for Local Recurrence of Prostatic Carcinoma—Abhishek Solanki, MD, MS\u003c\/li\u003e\n\u003cli\u003eReirradiation in Primary and Metastatic CNS Malignancy—Susan McGovern, MD, PhD\u003c\/li\u003e\n\u003cli\u003ePro Retreatment: Head and Neck—James Caudell, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eInoperable\/Recurrent Endometrial Cancer and Building a Brachytherapy Practice in a Community Setting\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eInoperable Endometrial Cancer—J. Spencer Thompson, MD\u003c\/li\u003e\n\u003cli\u003eRecurrent Endometrial Cancer—Emma Fields, MD\u003c\/li\u003e\n\u003cli\u003eImplementing a Successful Brachytherapy Program in the Community—Malolan Rajagopalan, MD, MBA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eManagement of Primary Brain Tumors in the Molecular Era and Building and Refining a Radiosurgery Program\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of Gliomas in the Molecular Era—Sara Hardy, MD, MS\u003c\/li\u003e\n\u003cli\u003eManagement of Large and Multiple Brain Metastases—Raju Raval, MD, DPhil\u003c\/li\u003e\n\u003cli\u003eStarting and Refining a Radiosurgery Program—Roshan Prabhu, MD, MS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eOligometastatic Disease: Practical Aspects of Metastasis-Directed Therapy in a Community Practice\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eData and Dose Selection: To Ablate or Not to Ablate?—Beant Gill, MD\u003c\/li\u003e\n\u003cli\u003ePrognostication, Timing, and Patient Selection—David Palma, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSetting Up for Success—Melissa O’Neil, MRT(T)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eMaximizing Patient Outcomes and Minimizing Morbidity in Gastrointestinal Cancer\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eOptimizing Multimodality Management of Gastroesophageal Junction Cancer—Edward Kim, MD\u003c\/li\u003e\n\u003cli\u003eTNT, W\u0026amp;W, and Beyond: Applying the Explosion of Data to Rectal Cancer Practice—Krishan Jethwa, MD\u003c\/li\u003e\n\u003cli\u003eAdvances in Radiation for Pancreatic Cancer—Erqi Pollom, MD, MS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003ePersonalization of Systemic Therapy for Localized to Metastatic Prostate Cancer\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePersonalizing ADT Use in the Definitive Treatment of Intermediate Risk Prostate Cancer—Angela Jia, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDuration and Combination of Systemic Therapies for Patients with High Risk, Node Positive, and Oligometastatic Prostate Cancer—Anne Rajkumar, MD\u003c\/li\u003e\n\u003cli\u003eOverview of Systemic Therapies in Metastatic Prostate Cancer—Rana Mckay, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954486808674,"sku":"MED-AMB04337","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/American-Society-for-Radiation-Oncology.jpg?v=1779377744","url":"https:\/\/meducourse.com\/products\/astro-practical-radiation-oncology-program-2023","provider":"Meducourse","version":"1.0","type":"link"}